Express Hits the Brakes in September
Clothing chain Express said business was going well in August, but then got detailed last month! As a result, third-quarter earnings will be no more than $0.20 a share, compared with previous guidance of $0.27 to $0.32. EXPR craters 17 percent before the bell on my tradeMONSTER platform.
Fifth & Pacific Drops After Guidace is Cut
Fifth & Pacific cut its guidance for full year EBITDA. It's now expected to be $100-110 million, down from an earlier estimate of $125-140 million. Management cited weak sales at Juicy Couture, which had been driving results. FNP falls drops 12 percent in early trading.
Drug Data Lifts Celgene
Celgene said that breast-cancer patients in a late-stage trial of its Abraxane drug showed statistically significant improvement in their conditions. That was just what the doctor ordered, and CELG is higher by almost 2 percent in the premarket.
Ctrip.com Advances on Raymond James Upgrade
Ctrip.com got an upgrade from Raymond James to "strong buy" from "market perform." The price target is $26, more than 50 percent above Monday's close. CTRP advances more than 4 percent in the premarket.
More From optionMONSTER
- Sarepta explodes higher on drug data
- Market holding its breath for key data
- Bullish trade tunes into Dish Network
- Investment & Company Information